Heritage Investors Management Corp raised its stake in McKesson Co. (NYSE:MCK) by 8.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 74,173 shares of the company’s stock after buying an additional 5,685 shares during the period. Heritage Investors Management Corp’s holdings in McKesson were worth $9,839,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Boston Partners grew its position in shares of McKesson by 54.5% in the 2nd quarter. Boston Partners now owns 6,237,042 shares of the company’s stock valued at $832,021,000 after buying an additional 2,200,669 shares during the last quarter. Vulcan Value Partners LLC grew its position in shares of McKesson by 7.8% in the 2nd quarter. Vulcan Value Partners LLC now owns 3,768,099 shares of the company’s stock valued at $502,664,000 after buying an additional 273,090 shares during the last quarter. Pzena Investment Management LLC grew its position in shares of McKesson by 7.6% in the 2nd quarter. Pzena Investment Management LLC now owns 2,836,710 shares of the company’s stock valued at $378,417,000 after buying an additional 201,062 shares during the last quarter. American Century Companies Inc. grew its position in shares of McKesson by 13.6% in the 3rd quarter. American Century Companies Inc. now owns 1,735,496 shares of the company’s stock valued at $230,214,000 after buying an additional 207,533 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its position in shares of McKesson by 3.4% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,424,630 shares of the company’s stock valued at $190,107,000 after buying an additional 46,386 shares during the last quarter. Hedge funds and other institutional investors own 89.19% of the company’s stock.
A number of equities research analysts have commented on MCK shares. Barclays reduced their price target on McKesson from $150.00 to $136.00 and set an “equal weight” rating on the stock in a research report on Friday, October 26th. Royal Bank of Canada set a $155.00 price target on McKesson and gave the company a “hold” rating in a research report on Friday, October 26th. JPMorgan Chase & Co. reduced their price target on McKesson from $181.00 to $160.00 and set an “overweight” rating on the stock in a research report on Friday, July 27th. ValuEngine upgraded McKesson from a “strong sell” rating to a “sell” rating in a research report on Monday, October 29th. Finally, Mizuho restated a “hold” rating and set a $133.00 target price on shares of McKesson in a research report on Sunday, August 12th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have given a buy rating to the stock. McKesson currently has an average rating of “Hold” and an average price target of $150.26.
McKesson (NYSE:MCK) last announced its earnings results on Thursday, October 25th. The company reported $3.60 EPS for the quarter, beating the consensus estimate of $3.28 by $0.32. McKesson had a return on equity of 26.55% and a net margin of 0.06%. The company had revenue of $53.08 billion for the quarter, compared to analyst estimates of $53.56 billion. Equities research analysts expect that McKesson Co. will post 13.41 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 2nd. Investors of record on Monday, December 3rd will be given a dividend of $0.39 per share. The ex-dividend date is Friday, November 30th. This represents a $1.56 annualized dividend and a dividend yield of 1.19%. McKesson’s payout ratio is 12.36%.
In related news, Director N Anthony Coles sold 1,350 shares of the company’s stock in a transaction dated Friday, August 31st. The stock was sold at an average price of $128.69, for a total transaction of $173,731.50. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.87% of the stock is owned by corporate insiders.
COPYRIGHT VIOLATION NOTICE: “Heritage Investors Management Corp Has $9.84 Million Holdings in McKesson Co. (MCK)” was posted by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this article on another website, it was illegally copied and republished in violation of international trademark and copyright laws. The original version of this article can be read at https://sportsperspectives.com/2018/11/10/heritage-investors-management-corp-has-9-84-million-holdings-in-mckesson-co-mck.html.
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.
Read More: Stop Order Uses For Individual Investors
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.